BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Imifoplatin readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of Imifoplatin\, from ClinicalTrials.gov est
 imates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT05104736-2170@assetmemo.bio
DTSTAMP:20261121T005632Z
DTSTART;VALUE=DATE:20271231
DTEND;VALUE=DATE:20280101
SUMMARY:Imifoplatin: Phase 2 readout est. (NCT05104736)
DESCRIPTION:Imifoplatin\, phase 2.\nStudy: PT-112 in Subjects With Thymoma 
 and Thymic Carcinoma\nEstimated primary completion: 31 December 2027. This
  is a ClinicalTrials.gov estimate\, not a confirmed readout date\, and it 
 can move.\nDrug page: https://assetmemo.bio/drug/imifoplatin#upcoming-even
 ts\nRegistry record: https://clinicaltrials.gov/study/NCT05104736
URL:https://assetmemo.bio/drug/imifoplatin#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
